Contribution of Organofluorine Compounds to Pharmaceuticals.

Inoue, Munenori; Sumii, Yuji; Shibata, Norio

Inoue, Munenori; Sumii, Yuji; Shibata, Norio.

Afiliação

Inoue M; Sagami Chemical Research Institute, 2743-1 Hayakawa, Ayase, Kanagawa 252-1193, Japan.
Sumii Y; Department of Life Science and Applied Chemistry, Department of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Gokiso, Showa-ku, Nagoya 466-5888, Japan.
Shibata N; Department of Life Science and Applied Chemistry, Department of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Gokiso, Showa-ku, Nagoya 466-5888, Japan.

ACS Omega ; 5(19): 10633-10640, 2020 May 19.

Article em En | MEDLINE | ID: mdl-32455181

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: ACS Omega Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google